Arcturus Therapeutics
ARCT
#8605
Rank
C$0.25 B
Marketcap
C$8.98
Share price
-8.56%
Change (1 day)
-60.11%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -C$0.11 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are C$85.14 Million. In 2024 the company made an earning of -C$0.13 Billion a decrease over its 2023 earnings that were of -C$37.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.11 Billion-16.53%
2024 -C$0.13 Billion240.24%
2023 -C$37.35 Million-298.78%
2022 C$18.78 M-106.79%
2021 -C$0.28 Billion181.83%
2020 -C$98.21 Million183.72%
2019 -C$34.62 Million16.93%
2018 -C$29.61 Million154.5%
2017 -C$11.64 Million-65.36%
2016 -C$33.59 Million25.93%
2015 -C$26.67 Million-41.04%
2014 -C$45.24 Million219.64%
2013 -C$14.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
C$37.96 M-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-C$2.98 Million-97.12% Bahamas